The role of the ErbB4 and ErbB3 neuregulin receptors in intestinal epithelial regeneration
ErbB4 和 ErbB3 神经调节蛋白受体在肠上皮再生中的作用
基本信息
- 批准号:9901504
- 负责人:
- 金额:$ 42.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteApoptosisCD3 AntigensCell CountCell Differentiation processCellsCensusesChronicDataDevelopmentEnterocytesEpithelialEpithelial CellsEpitheliumEquilibriumErbB4 geneFundingFutureGastrointestinal InjuryGrowth FactorHealthHeterodimerizationHomeostasisHypoxia Inducible FactorInflammatoryInflammatory Bowel DiseasesInjuryIntestinesKnowledgeLGR5 geneLigandsLinkMAP Kinase GeneModelingMolecularMusNRG1 geneNatural regenerationNeuregulin ReceptorNeuregulinsPaneth CellsPathway interactionsPatientsPlayPopulationPublishingRadiation InjuriesRadiation exposureRadiation therapyReceptor Protein-Tyrosine KinasesRecoveryReserve Stem CellRodent ModelRoleSecretory CellSignal TransductionSupporting CellTestingcell regenerationcellular targetingchemotherapycytokinedesignepithelial stem cellepithelium regenerationin vitro Modelin vivoinflammatory disease of the intestineinjury recoveryintestinal cryptintestinal epitheliumintestinal homeostasisneuregulin-4notch proteinnovelradiation effectradiation responsereceptorrepairedself-renewalside effectstem cell nichestem cell populationstem cellstherapeutic targetvillin
项目摘要
PROJECT SUMMARY
The receptor tyrosine kinases ErbB4 and ErbB3 can protect intestinal enterocytes from
apoptosis, but their potential roles in inducing stem cell regeneration after an insult—arguably of
equal importance in the face of challenge—are not known. Here, we aim to define the function
of ErbB3 and ErbB4 in post-injury recovery of intestinal stem cells, and thus in regeneration of
the epithelium. ErbB4 expression is high in regenerating enteroids, and the ErbB4 ligand NRG4
promotes crypt plating efficiency. ErbB4-null enteroid cultures have a compromised intestinal
stem cell niche with loss of the rapidly-cycling stem cell marker Lgr5 and reduced Paneth cell
numbers. Similar to ErbB4, ErbB3 promotes enterocyte survival, but unlike ErbB4 it suppresses
secretory cell differentiation; for example, ErbB3-null enteroids have an expanded Paneth cell
census. Thus, the two neuregulin receptors seem to play complementary but distinct roles in
regulating renewal and development in the crypt. Preliminary data suggest that both of these
receptors are induced during recovery from injury models in vitro and in vivo, and loss of either
perturbs recovery. We will build on our published and preliminary data to test the hypothesis
that signaling through ErbB4 and ErbB3 promotes balanced regeneration of the intestinal
epithelium after injury. We will (1) define the impact of ErbB4 or ErbB3 loss or activation on
intestinal epithelial regeneration after injury, (2) determine the molecular mechanisms linking
ErbB4 and ErbB3 to intestinal stem cell regeneration, especially connections to the fundamental
regulators of stem cell self-renewal, Wnt and Notch. These studies will advance basic
understanding of how intestinal stem cells and the stem cell niche are repaired, as well as
identify novel regulatory mechanisms that could be future therapeutic targets to drive intestinal
regeneration after injury.
项目摘要
受体酪氨酸激酶ERBB4和ERBB3可以保护肠肠上皮细胞免受
凋亡,但它们在受伤后的诱导干细胞再生中的潜在作用 - 可以
面对挑战的同等重要性 - 不知道。在这里,我们旨在定义功能
ERBB3和ERBB4在肠道干细胞的伤害后恢复中
上皮。 ERBB4的表达在再生肠todi中很高,ERBB4配体NRG4
促进加密电镀效率。 Erbb4-null Enteroid培养物的肠道受损
干细胞小众,损失了快速循环的干细胞标记LGR5并减少了Paneth细胞
数字。与ERBB4相似,ERBB3促进肠球菌的生存,但与ERBB4不同,它抑制了
秘书细胞分化;例如,ERBB3无效的肠todotoids具有扩展的paneth细胞
人口普查。那两个神经蛋白接收器似乎在
调节地下室的更新和发展。初步数据表明这两个
在体外和体内从损伤模型中恢复期间诱导受体,并丧失任何一个
Perturbs恢复。我们将基于我们已发布的初步数据来检验假设
通过ERBB4和ERBB3发出信号会促进肠道的平衡再生
受伤后上皮。我们将(1)定义ERBB4或ERBB3损失或激活对
损伤后肠上皮再生,(2)确定连接的分子机制
ERBB4和ERBB3到肠道干细胞再生,尤其是与基本的连接
干细胞自我更新,Wnt和Notch的调节剂。这些研究将提高基本
了解如何修复肠道干细胞和干细胞生态位
确定可能是未来的治疗靶标的新型调节机制
受伤后再生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark R Frey其他文献
Mark R Frey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark R Frey', 18)}}的其他基金
The Gastrointestinal Epithelium Conference - Interface with the Outside World
胃肠上皮会议 - 与外界的接口
- 批准号:
10753753 - 财政年份:2023
- 资助金额:
$ 42.21万 - 项目类别:
The role of SPRY2 in the colonic epithelial response to inflammation
SPRY2在结肠上皮炎症反应中的作用
- 批准号:
10409691 - 财政年份:2019
- 资助金额:
$ 42.21万 - 项目类别:
The role of SPRY2 in the colonic epithelial response to inflammation
SPRY2在结肠上皮炎症反应中的作用
- 批准号:
10164769 - 财政年份:2019
- 资助金额:
$ 42.21万 - 项目类别:
Regulation of Colon Epithelial Cell Survival by NRG4-ErbB4 Signaling
NRG4-ErbB4 信号传导对结肠上皮细胞存活的调节
- 批准号:
8506837 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
The role of the ErbB4 and ErbB3 neuregulin receptors in intestinal epithelial regeneration
ErbB4 和 ErbB3 神经调节蛋白受体在肠上皮再生中的作用
- 批准号:
10163158 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Regulation of Colon Epithelial Cell Survival by NRG4-ErbB4 Signaling
NRG4-ErbB4 信号传导对结肠上皮细胞存活的调节
- 批准号:
8629735 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Regulation of Colon Epithelial Cell Survival by NRG4-ErbB4 Signaling
NRG4-ErbB4 信号传导对结肠上皮细胞存活的调节
- 批准号:
9063537 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
The role of the ErbB4 and ErbB3 neuregulin receptors in intestinal epithelial regeneration
ErbB4 和 ErbB3 神经调节蛋白受体在肠上皮再生中的作用
- 批准号:
10404521 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Regulation of Colon Epithelial Cell Survival by NRG4-ErbB4 Signaling
NRG4-ErbB4 信号传导对结肠上皮细胞存活的调节
- 批准号:
8851584 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Regulation of cyclooxygenase-2 by ErbB4 in colon epithelial cells
ErbB4 对结肠上皮细胞中环氧合酶 2 的调节
- 批准号:
8031551 - 财政年份:2011
- 资助金额:
$ 42.21万 - 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
慢性心力衰竭期间 T 淋巴细胞时间调节的新型抑制剂
- 批准号:
10638340 - 财政年份:2023
- 资助金额:
$ 42.21万 - 项目类别:
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) trial
Senolytics 减缓脓毒症进展 (STOP-Sepsis) 试验
- 批准号:
10434283 - 财政年份:2022
- 资助金额:
$ 42.21万 - 项目类别:
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) trial
Senolytics 减缓脓毒症进展 (STOP-Sepsis) 试验
- 批准号:
10663888 - 财政年份:2022
- 资助金额:
$ 42.21万 - 项目类别:
Development of Full Thickness Human Skin Perfusion Model for Testing Medical Countermeasures against Radiation Induced Skin Injuries
开发全层人体皮肤灌注模型,用于测试辐射引起的皮肤损伤的医疗对策
- 批准号:
10216778 - 财政年份:2021
- 资助金额:
$ 42.21万 - 项目类别:
Development of Full Thickness Human Skin Perfusion Model for Testing Medical Countermeasures against Radiation Induced Skin Injuries
开发全层人体皮肤灌注模型,用于测试辐射引起的皮肤损伤的医疗对策
- 批准号:
10380774 - 财政年份:2021
- 资助金额:
$ 42.21万 - 项目类别: